TumorGenesis
TumorGenesis Inc. specializes in media that help cancer cells grow outside the patient’s body and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. This platform, along with other proprietary FDA-approved technologies from Helomics, is used to fuel unique and more clinically actionable data for our predictive models.
25
Ovarian cancer cell lines
90%
of ovarian cancers represented
178+
Medium formulations
Let us tell you about TumorGenesis.
TumorGenesis currently has a living library of ovarian cancer cell lines that represent most of the ovarian cancer found around the world today.
Clinical
Testing
Helomics helps to personalize patient therapies
Drug
Discovery
Helomics database of 150K+ tumors aids in reducing discovery timeline
Oncology
Research
TumorGenesis develops living tumors outside the body for study and testing
Drug
Development
Soluble Biotech supplies formulations for delivery of therapeutics and vaccines
Cell
Cultures
zPREDICTA utilizes tumor-specific 3D cell culture models, enabling more successful drug development
What problems do we solve?
TumorGenesis makes living tumors readily available to researchers.